Cargando…
P08 The quality of life and cost benefits of domiciliary 24-hour piperacillin/tazobactam 13.5 g infusion in patients with necrotizing otitis externa
BACKGROUND: The incidence of necrotizing otitis externa (NOE) is increasing with the rise in the population who are elderly or immunocompromised. Currently there is no consensus on an antibiotic regimen for NOE but in a recent survey of otolaryngologists, 90% recommended using IV antibiotics.(1,2) A...
Autores principales: | Sacranie, Y., Fleming, N., Smith, W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849336/ http://dx.doi.org/10.1093/jacamr/dlac004.007 |
Ejemplares similares
-
P09 The use of ESR and pain scores to determine the duration of antibiotic therapy in patients with necrotizing otitis externa
por: Sacranie, Yasir, et al.
Publicado: (2022) -
Necrotizing Otitis Externa
por: Suyama, Yasuhiro, et al.
Publicado: (2018) -
Bilateral hipoglossal nerve palsy in necrotizing otitis externa
por: Fonseca, Adriano Santana, et al.
Publicado: (2015) -
Piperacillin/Tazobactam (ZOSYN)
por: Culver, Stephanie M., et al.
Publicado: (1996) -
Piperacillin/tazobactam administered by continuous or intermittent infusion for the treatment of nosocomial pneumonia
por: Lorente, L, et al.
Publicado: (2009)